Approval · Notice of Compliance 2793 · 1998
APO-CEFACLOR: Notice of Compliance 2793
Issued March 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2793
- Date
- March 6, 1998
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New dosage form and strengths
- Therapeutic class
- Antibiotic
- Canadian reference product
- CECLOR (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-CEFACLOR | 02237500 | Cancelled Post Market |
| APO-CEFACLOR | 02237501 | Cancelled Post Market |
| APO-CEFACLOR | 02237502 | Cancelled Post Market |